Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients

Summary

In this study, the safety, tolerability and efficacy of DLX105 administered topically onto the psoriatic lesion of mild-to-moderate psoriasis patients will be investigated.

Timeline

Start

2013-08

Primary completion

2014-06

Completion

2014-07

Drugs

Indications